// App-Quantinova.ai

: SIGNIFICANCE OF ANTINUCLEAR ANTIBODIES IN PRIMARY IMMUNE THROMBOCYTOPENIA. RESULTS OF THE CARMEN REGISTRY.

Researchers

Presenter

  • Guillaume Moulis

Principal Investigators

  • Thibault Comont

  • Johanne Germain

  • Agns Sommet

  • Maryse Lapeyre-Mestre

  • Odile Beyne-Rauzy

  • Daniel Adoue

Medical Centers

  • Toulouse University Hospital, Toulouse, France

  • GINECO, Toulouse, France

  • CIC 1436, Toiulouse, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Autoimmune (AI)

  • Gastroenterology (GU)

Disease

  • Immune thrombocytopenia

  • Gastrointestinal bleeding

  • Thrombocytopenia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Lercanidipine hydrochloride

Outcome

  • N/A


Study Design

  • Multinational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A